Oramed Pharmaceuticals Stock
Price
Target price
€1.84
€1.84
-0.910%
-0.017
-0.910%
-
25.06.25 / Stuttgart Stock Exchange
WKN: A1CTNU / Symbol: ORMP / Name: Oramed / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Oramed Pharmaceuticals Stock
The price for the Oramed Pharmaceuticals stock decreased slightly today. Compared to yesterday there is a change of -€0.017 (-0.910%).
For the coming years our community has positive and negative things to say abot the Oramed Pharmaceuticals stock. Criterium "Brand" gathered the most positive votes but regarding "Brand" there were negative voices in the community.
Oramed is a pharmaceutical company that focuses on the development of innovative oral delivery solutions for drugs that are traditionally administered through injection. The company is primarily dedicated to the development of an oral insulin capsule that can potentially revolutionize the treatment of diabetes. Their flagship product, ORMD-0801, is currently in Phase III clinical trials in the United States and has received Fast Track designation from the FDA. Oramed is a publicly traded company listed on the Nasdaq under the ticker symbol ORMP.
Pros and Cons of Oramed Pharmaceuticals in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oramed Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals | -0.910% | -0.801% | -0.295% | -5.372% | -15.791% | -65.786% | -42.991% |
| Enlivex Therapeutics Ltd. | 2.040% | 7.104% | 16.667% | -20.325% | -12.500% | -76.722% | -81.682% |
| Krystal Biotech | 3.730% | 7.555% | 12.591% | -26.542% | -18.627% | 90.538% | - |
| Ardelyx Inc. | -1.150% | 2.229% | -9.752% | -43.623% | -36.254% | 455.556% | -48.952% |
Comments
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for ORMP provided by MarketBeat
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for ORMP provided by MarketBeat
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for ORMP provided by MarketBeat